Actively Recruiting

Phase Not Applicable
Age: 18Years +
FEMALE
ID07211867

A Digital Intervention to Decrease Self-Stigma Among Pregnant and Postpartum Women With Substance Use Disorder

Led by Washington University School of Medicine · Updated on 2025-11-26

152

Participants Needed

1

Research Sites

8 weeks

Total Duration

On this page

Sponsors

W

Washington University School of Medicine

Lead Sponsor

N

National Institute on Drug Abuse (NIDA)

Collaborating Sponsor

AI-Summary

What this Trial Is About

This research aims to evaluate a digital intervention called Enhearten designed to reduce self-stigma and improve substance use disorder (SUD) treatment and recovery outcomes among pregnant and postpartum women (PPW) with SUDs. The study will test how feasible, acceptable, and effective Enhearten is in supporting adherence to medications for addiction treatment (MAT) while addressing the unique challenges and stigma faced by PPW. This trial is a randomized controlled study conducted at multiple centers to examine these effects over time. Participants will be randomly assigned to one of two groups: one group will use the Enhearten digital intervention with a stigma-focused ecological momentary intervention (EMI) that screens for feelings of stigma and provides just-in-time support, while the other group will be on a waitlist and receive access to Enhearten after the trial. Enhearten is tailored to encourage treatment retention and reduce self-stigma specifically for pregnant and postpartum women, adapting its features to their needs. During the study, participants will be monitored from baseline through six months after the intervention for changes in self-stigma and internalized stigma related to substance use. Researchers will also track medication use for addiction treatment, substance use and cravings, attitudes and self-efficacy towards treatment, mental health symptoms, and infant feeding intentions. The study will collect data on the usability and acceptability of the intervention from one to six months post-intervention. Overall participation will involve regular assessments to measure these outcomes and understand the intervention's impact on recovery and treatment adherence.

CONDITIONS

Brief Title

A Digital Intervention to Decrease Self-Stigma Among Pregnant and Postpartum Women With Substance Use Disorder

Who Can Participate

Age: 18Years +
FEMALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Pregnant women and new mothers up to 12 months postpartum
  • Adults 18 years of age or older
  • Fluent in English
  • Daily access to a smartphone or tablet to use the Enhearten app
  • Self-reported history of substance use excluding alcohol, nicotine/tobacco, and prescribed drugs, or documented history confirmed by healthcare provider
Not Eligible

You will not qualify if you...

  • Significant cognitive impairment that affects ability to consent or complete study tasks as reported by participant or documented by healthcare provider

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person or remote)

Treatment

Duration - 6 months

Participants use the Enhearten digital intervention designed to reduce self-stigma and support adherence to medications for addiction treatment during pregnancy and postpartum, or are assigned to a waitlist control group.

Regular digital engagement with the app; assessments at baseline and periodically through 6 months

Follow-up

Duration - Up to 6 months post-treatment

Participants continue to be assessed for self-stigma, substance use, treatment retention, and mental health outcomes up to 6 months post-intervention.

Periodic assessments via digital surveys or calls

Trial Site Locations

Total: 1 location

1

Washington University School of Medicine

St Louis, Missouri, United States, 63110

Actively Recruiting

Loading map...

Research Team

A

Alex T Ramsey, Ph.D.

E

Elecia Worley, MSW

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Similar Trials

A Type I Hybrid Effectiveness-Implementation Trial of Mother...

Substance Use Disorder

Actively Recruiting

1 location

Defining Neurobiological Links Between Substance Use and Men...

Major Depressive Disorder

Actively Recruiting

1 location

Examining Early Intervention Obstructive Sleep Apnea Treatme...

Post Traumatic Stress Disorder

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here